Literature DB >> 17700589

The star-allele nomenclature: retooling for translational genomics.

J D Robarge1, L Li, Z Desta, A Nguyen, D A Flockhart.   

Abstract

The star-allele nomenclature is the result of efforts to standardize genetic polymorphism annotation for the cytochrome P450 genes. As clinical pharmacogenetic testing becomes widespread, it is important that this system effectively communicate a patient's genotype and predicted clinical phenotype. As genomics research expands, it is equally important that the system remain a valuable tool for the wider community of genetic researchers to exploit our ever-improving ability to catalog variability in the human genome.

Entities:  

Mesh:

Year:  2007        PMID: 17700589     DOI: 10.1038/sj.clpt.6100284

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  26 in total

Review 1.  Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17.

Authors:  Alain Li-Wan-Po; Thierry Girard; Peter Farndon; Candy Cooley; James Lithgow
Journal:  Br J Clin Pharmacol       Date:  2010-03       Impact factor: 4.335

2.  Supporting interoperability of genetic data with LOINC.

Authors:  Jamalynne Deckard; Clement J McDonald; Daniel J Vreeman
Journal:  J Am Med Inform Assoc       Date:  2015-02-05       Impact factor: 4.497

Review 3.  Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing.

Authors:  Yao Yang; Mariana R Botton; Erick R Scott; Stuart A Scott
Journal:  Pharmacogenomics       Date:  2017-05-04       Impact factor: 2.533

Review 4.  Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.

Authors:  L V Kalman; Jag Agúndez; M Lindqvist Appell; J L Black; G C Bell; S Boukouvala; C Bruckner; E Bruford; K Caudle; S A Coulthard; A K Daly; Al Del Tredici; J T den Dunnen; K Drozda; R E Everts; D Flockhart; R R Freimuth; A Gaedigk; H Hachad; T Hartshorne; M Ingelman-Sundberg; T E Klein; V M Lauschke; D R Maglott; H L McLeod; G A McMillin; U A Meyer; D J Müller; D A Nickerson; W S Oetting; M Pacanowski; V M Pratt; M V Relling; A Roberts; W S Rubinstein; K Sangkuhl; M Schwab; S A Scott; S C Sim; R K Thirumaran; L H Toji; R F Tyndale; Rhn van Schaik; M Whirl-Carrillo; Ktj Yeo; U M Zanger
Journal:  Clin Pharmacol Ther       Date:  2015-11-20       Impact factor: 6.875

5.  STRATEGIES FOR EQUITABLE PHARMACOGENOMIC-GUIDED WARFARIN DOSING AMONG EUROPEAN AND AFRICAN AMERICAN INDIVIDUALS IN A CLINICAL POPULATION.

Authors:  Laura K Wiley; Jacob P Vanhouten; David C Samuels; Melinda C Aldrich; Dan M Roden; Josh F Peterson; Joshua C Denny
Journal:  Pac Symp Biocomput       Date:  2017

6.  Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein).

Authors:  Laura M Hodges; Svetlana M Markova; Leslie W Chinn; Jason M Gow; Deanna L Kroetz; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-03       Impact factor: 2.089

7.  Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.

Authors:  Victoria M Pratt; Robin E Everts; Praful Aggarwal; Brittany N Beyer; Ulrich Broeckel; Ruth Epstein-Baak; Paul Hujsak; Ruth Kornreich; Jun Liao; Rachel Lorier; Stuart A Scott; Chingying Huang Smith; Lorraine H Toji; Amy Turner; Lisa V Kalman
Journal:  J Mol Diagn       Date:  2015-11-24       Impact factor: 5.568

8.  A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical record.

Authors:  J K Hicks; K R Crews; J M Hoffman; N M Kornegay; M R Wilkinson; R Lorier; A Stoddard; W Yang; C Smith; C A Fernandez; S J Cross; C Haidar; D K Baker; S C Howard; W E Evans; U Broeckel; M V Relling
Journal:  Clin Pharmacol Ther       Date:  2012-09-19       Impact factor: 6.875

Review 9.  Clinically relevant genetic variations in drug metabolizing enzymes.

Authors:  Navin Pinto; M Eileen Dolan
Journal:  Curr Drug Metab       Date:  2011-06       Impact factor: 3.731

10.  The CYP2D6 VCF Translator.

Authors:  W Qiao; J Wang; B S Pullman; R Chen; Y Yang; S A Scott
Journal:  Pharmacogenomics J       Date:  2016-03-15       Impact factor: 3.550

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.